A Study to Learn About the Study Medicine Called PF-08165784 in People With PIK3CA-Mutated Advanced or Metastatic Solid Tumors (clinicaltrials.gov) - Oct 28, 2026 - P1 | N=268 | Not yet recruiting | Sponsor: Pfizer
Monotherapy • New P1 trial • Breast Cancer • Colorectal Adenocarcinoma • Colorectal Cancer • Hormone Receptor Positive Breast Cancer • Oncology • Solid Tumor • HER-2 • PIK3CA
|